209 top medical experts on Endocardial Fibroelastosis across 19 countries and 14 U.S. states, including 59 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Endocardial Fibroelastosis: A condition characterized by the thickening of endocardium due to proliferation of fibrous and elastic tissue, usually in the left ventricle leading to impaired cardiac function (cardiomyopathy, restrictive). It is most commonly seen in young children and rarely in adults. It is often associated with congenital heart anomalies (heart defects congenital;) infection; or gene mutation. Defects in the tafazzin protein, encoded by TAZ gene, result in a form of autosomal dominant familial endocardial fibroelastosis.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Cardiomyopathies (4,479) and Narrower Categories: Isolated Noncompaction of the Ventricular Myocardium (2,378).


  

        

                    


    Computing Expert Listing ...

);